98%
921
2 minutes
20
This study investigated the association between adherence to the Mediterranean diet (MD) and new-onset hypertension (HTN) in a cohort of community-dwelling, middle-aged, older Korean individuals with obesity. We used data from the Korean Genome and Epidemiology Study, a population-based prospective cohort study. The Korean version of the MD Adherence Screener was used to evaluate compliance with the MD. The primary endpoint was the incidence of new-onset HTN. Cox proportional hazard models were used to estimate the hazard ratio (HR) and 95% confidence interval for HTN incidence with increasing MD adherence. Data from 1995 participants with obesity without HTN at baseline were analyzed. After adjusting for confounders, participants with moderate (Group 2) and high adherence (Group 3) to the MD had HRs for new-onset HTN of 0.72 (0.57-0.90) and 0.73 (0.56-0.95), respectively, compared with those with low adherence (Group 1). Sex and age differences were associated with MD adherence and HTN incidence. The association between MD adherence and HTN incidence was only significant in males and in participants aged 40-64 years. There was no significant association between MD adherence and new-onset HTN in females or those aged ≥ 65 years. In conclusion, this study found a significant association between adherence to the MD and a reduction in new-onset HTN in Korean adults with obesity. Considering its value and sustainability, the adoption of the MD may contribute to the prevention of new-onset HTN in populations with obesity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774040 | PMC |
http://dx.doi.org/10.1111/jch.14951 | DOI Listing |
Am J Hypertens
August 2025
Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Background: Data on risk factors for new-onset atrial fibrillation (NOAF) in hypertensive Asian populations are limited. This study aimed to identify predictors of NOAF in Thai adults with hypertension (HTN).
Methods: We conducted a retrospective cohort study of adults (≥18 years) newly diagnosed with HTN at Ramathibodi Hospital, Bangkok, from 2010 to 2023.
Cureus
June 2025
Internal Medicine, Aiken Regional Medical Centers, Aiken, USA.
In the dawn of the modern era, hypertension is still prevalent globally. Regardless of age and gender, thiazide diuretics, calcium channel blockers, and renin-angiotensin inhibitors remain the first line of treatment. Drug-induced hyponatremia is a side effect of thiazide diuretics.
View Article and Find Full Text PDFUrology
July 2025
Division of Urology, Department of Surgery, University of Utah Hospital, Salt Lake City, UT.
Objective: To evaluate the risk of new-onset hypertension (HTN) after renal trauma (rT) using a large insurance claims database.
Methods: We conducted a retrospective analysis of Merative MarketScan records from 2011-2017. Patients with rT were compared to controls with isolated bladder or urethral trauma.
Prev Med Rep
September 2025
Department of Cardiology, Institute of Cardiovascular Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, China.
Objective: This study aimed to investigate the relationship between comprehensive sleep patterns and the incidence of new-onset hypertension (HTN) and cardiovascular disease (CVD) in individuals with prehypertension.
Methods: This analysis included 118,523 baseline participants from the UK Biobank (2006-2010) with follow-up through 31 December 2021. A sleep pattern included chronotype, sleep duration, insomnia, snoring, and excessive daytime sleepiness.
Cancer
July 2025
Department of Pediatrics, Arkansas Children's Hospital, Little Rock, Arkansas, USA.
Background: Multitargeted tyrosine kinase inhibitors (MTKIs) have increasingly been used for the treatment of pediatric and young adult patients with solid tumors. Whereas cardiac toxicity is documented in adults, data remain limited in pediatrics. This study sought to characterize the incidence and outcomes of acute cardiotoxicity in pediatric patients with solid tumors treated with an MTKI.
View Article and Find Full Text PDF